deferiprone has been researched along with Arthritis in 4 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Arthritis: Acute or chronic inflammation of JOINTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A thalassaemic girl presented with agranulocytosis, arthritis of both ankles and clinical and laboratory features consistent with the diagnosis of systemic vasculitis, during oral iron chelator L1 (deferiprone) treatment." | 7.69 | Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone). ( Castriota-Scanderbeg, A; Sacco, M, 1997) |
| "Deferiprone (DFP), the first oral iron chelator, has been used in patients with beta-thalassemia major to reduce serum ferritin levels and total iron burden, leading to decreased cardiac iron levels." | 4.84 | Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature. ( Perifanis, V; Tsatra, I; Tsayas, I; Tselios, K; Vlachaki, E, 2008) |
| "A thalassaemic girl presented with agranulocytosis, arthritis of both ankles and clinical and laboratory features consistent with the diagnosis of systemic vasculitis, during oral iron chelator L1 (deferiprone) treatment." | 3.69 | Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone). ( Castriota-Scanderbeg, A; Sacco, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noureldine, MHA | 1 |
| Taher, AT | 1 |
| Haydar, AA | 1 |
| Berjawi, A | 1 |
| Khamashta, MA | 1 |
| Uthman, I | 1 |
| Vlachaki, E | 1 |
| Tselios, K | 1 |
| Perifanis, V | 1 |
| Tsatra, I | 1 |
| Tsayas, I | 1 |
| al-Refaie, FN | 1 |
| Hershko, C | 1 |
| Hoffbrand, AV | 1 |
| Kosaryan, M | 1 |
| Olivieri, NF | 1 |
| Tondury, P | 1 |
| Wonke, B | 1 |
| Castriota-Scanderbeg, A | 1 |
| Sacco, M | 1 |
2 reviews available for deferiprone and Arthritis
| Article | Year |
|---|---|
Rheumatological complications of beta-thalassaemia: an overview.
Topics: Arthritis; beta-Thalassemia; Blood Transfusion; Connective Tissue Diseases; Deferiprone; Femur Head | 2018 |
Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature.
Topics: Adult; Arthritis; beta-Thalassemia; Deferiprone; Humans; Iron Chelating Agents; Knee Joint; Male; Py | 2008 |
2 other studies available for deferiprone and Arthritis
| Article | Year |
|---|---|
Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators.
Topics: Adult; Agranulocytosis; Arthritis; beta-Thalassemia; Chemical and Drug Induced Liver Injury; Deferip | 1995 |
Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone).
Topics: Adult; Agranulocytosis; Arthritis; beta-Thalassemia; Deferiprone; Female; Humans; Pyridones; Vasculi | 1997 |